Home » Expert Content » Clinical Supply Management » Implementing a Stability Strategy for Short Expiry IMPs

Implementing a Stability Strategy for Short Expiry IMPs

Summary: Different clinical trials have different supply needs and strategies. This recent Q&A article published in Pharmaceutical Technology features Charlotte Margetson, clinical supplies manager at Catalent. Download the article to learn about stability strategy for clinical trials, the importance of supply chain communication, automated control systems and country-specific labeling protocols.

Click here to download article.